Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,167,632
  • Shares Outstanding, K 1,768,456
  • Annual Sales, $ 30,578 M
  • Annual Income, $ 2,368 M
  • 60-Month Beta 1.12
  • Price/Sales 4.93
  • Price/Cash Flow 17.74
  • Price/Book 4.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.95
  • Number of Estimates 8
  • High Estimate 0.95
  • Low Estimate 0.94
  • Prior Year 0.81
  • Growth Rate Est. (year over year) +17.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.36 +3.79%
on 11/21/19
85.97 -0.57%
on 11/27/19
+2.36 (+2.84%)
since 11/06/19
3-Month
78.51 +8.88%
on 10/08/19
86.43 -1.10%
on 09/09/19
-0.56 (-0.65%)
since 09/06/19
52-Week
65.44 +30.62%
on 12/24/18
88.76 -3.70%
on 07/23/19
+13.94 (+19.49%)
since 12/06/18

Most Recent Stories

More News
SmarTrend Watching for Potential Pullback in Shares of Abbott Labs After 1.42% Gain

Abbott Labs (NYSE:ABT) traded in a range yesterday that spanned from a low of $85.38 to a high of $85.80. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $85.42...

ABT : 85.48 (+0.28%)
Global Spinal Cord Stimulation (SCS) Market Report 2019-2023 Featuring Profiles of Leading Players Abbott Laboratories, Medtronic, Boston Scientific, and Nevro - ResearchAndMarkets.com

The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering.

ABT : 85.48 (+0.28%)
BSX : 44.08 (+1.90%)
MDT : 113.09 (+0.79%)
Abbott (ABT) Dips More Than Broader Markets: What You Should Know

Abbott (ABT) closed at $84.51 in the latest trading session, marking a -1.1% move from the prior day.

ABT : 85.48 (+0.28%)
Relatively Good Performance Detected in Shares of Idexx Labs in the Health Care Equipment Industry (IDXX , BSX , ABT , SYK , HOLX )

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

ABT : 85.48 (+0.28%)
BSX : 44.08 (+1.90%)
IDXX : 251.37 (-0.19%)
Digital Diabetes Management Gains Momentum: 3 Stocks in Focus

With digital diabetes management space rapidly gaining momentum, patients with diabetes can look forward to better and improved outcomes.

RHHBY : 38.5700 (+0.36%)
ABT : 85.48 (+0.28%)
TNDM : 61.22 (-1.07%)
DXCM : 224.76 (-0.90%)
MDT : 113.09 (+0.79%)
PODD : 183.96 (-0.15%)
Global Immunoassay Market Outlook and Forecast to 2025 - Leading Vendors are Roche Diagnostics, bioMerieux, Abbott Laboratories, Becton Dickinson & Company, and Siemens Healthineers

The "Immunoassay Market By Products and Services (Instruments, Reagents & Kits, Software & Services), By Applications (Oncology, Infectious Disease Testing, Cardiology, Endocrinology, Autoimmune Disease,...

ABT : 85.48 (+0.28%)
BDX : 260.69 (+0.69%)
Intersect ENT Announces Appointment of New Chief Financial Officer

Intersect ENT(R), Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Richard A. (Randy) Meier as Executive...

ABT : 85.48 (+0.28%)
OMI : 7.54 (+6.65%)
XENT : 21.11 (-1.36%)
BMRN : 79.92 (-0.20%)
Shares of Abiomed Inc Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (ABMD , RMD , ABT , ISRG , DHR )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ABT : 85.48 (+0.28%)
ABMD : 189.22 (+0.08%)
RMD : 150.59 (+0.27%)
Gastrointestinal Therapeutics Market Study of Future Value Chain on Volume, Share, Revenue and Size Insights 2019-2028

ABT : 85.48 (+0.28%)
AGN : 186.37 (+0.16%)
AZN : 47.68 (+0.13%)
BAYRY : 19.1200 (-0.26%)
GSK : 45.51 (+0.66%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Top Analyst Reports for Abbott, Philip Morris & Lowe's

Top Analyst Reports for Abbott, Philip Morris & Lowe's

PNC : 153.81 (+1.06%)
PM : 83.25 (+1.06%)
LOW : 116.28 (+0.61%)
KMI : 19.75 (+0.36%)
EQIX : 559.19 (-0.16%)
ABT : 85.48 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ABT with:

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 86.12
1st Resistance Point 85.80
Last Price 85.48
1st Support Level 85.27
2nd Support Level 85.06

See More

52-Week High 88.76
Last Price 85.48
Fibonacci 61.8% 79.85
Fibonacci 50% 77.10
Fibonacci 38.2% 74.35
52-Week Low 65.44

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar